U.S. Hospitality Stock News

NasdaqGM:BBNX
NasdaqGM:BBNXMedical Equipment

Does Beta Bionics (BBNX) Strong Q4 Sales Outlook Reshape Confidence in Its Long-Term Strategy?

Beta Bionics, Inc. has released preliminary, unaudited guidance indicating that net sales for the fourth quarter of 2025 are expected to be at least US$32.0 million, compared with US$20.4 million in the same period of 2024, and plans to report full results on February 17, 2026. The company is also organizing in-person investor meetings in San Francisco in mid-January 2026, underscoring management’s effort to highlight recent operating momentum and engage more directly with the investment...
NasdaqGS:XERS
NasdaqGS:XERSPharmaceuticals

Is Xeris Biopharma Holdings (XERS) Price Rally Still Justified After Recent Company Updates

If you are looking at Xeris Biopharma Holdings and wondering whether the recent excitement still offers fair value, this article will walk you through what the current price might be implying. The stock last closed at US$7.93, with returns of 7.9% over the past week, 14.3% over the past month, 7.9% year to date, and 133.2% over the last year, along with a very large 3 year return that is more than 5x. Recent company news has put a spotlight on Xeris Biopharma Holdings, adding context to...